Home/ Stocks/ KRYS

Krystal Biotech, Inc. Common Stock

KRYS XNAS

$300.88 +0.63 (+0.21%) ▲ 15-min delayed

Open

$298.31

High

$305.60

Low

$297.52

Volume

234.2K

Market Cap

$8.92B

About Krystal Biotech, Inc. Common Stock

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 295 Website →

Related Market News

No specific coverage for KRYS yet. Check out our latest market news or earnings calendar.

Get KRYS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Krystal Biotech, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.